作者
Rohit R. Badia,Dreaux Abe,Daniel Wong,Nirmish Singla,Anna Savelyeva,Nathan Chertack,Solomon L. Woldu,Yair Lotan,Ryan Mauck,Dan Ouyang,Xiaosong Meng,Cheryl Lewis,Kuntal Majmudar,Liwei Jia,Payal Kapur,Lin Xu,A. Lindsay Frazier,Vitaly Margulis,Douglas W. Strand,Nicholas Coleman,Matthew J. Murray,James F. Amatruda,John T. Lafin,Aditya Bagrodia
摘要
Current serum tumor markers for testicular germ cell tumor are limited by low sensitivity. Growing evidence supports the use of circulating miR-371a-3p as a superior marker for malignant (viable) germ cell tumor management. We evaluated the real-world application of serum miR-371a-3p levels in detecting viable germ cell tumor among patients undergoing partial or radical orchiectomy.